Lori Anne Kunkel
Director · 3 filings · Latest: Jul 6, 2026
Enliven Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
ELVN | Lori Anne Kunkel | Director | Jul 6, 2026 | Sale | $50.49 | 10,000 | $504.9K | 41,884 | |
ELVN | Lori Anne Kunkel | Director | Jun 5, 2026 | Sale | $34.54 | 10,000 | $345.4K | 51,884 | |
ELVN | Kunkel Lori Anne | — | Jun 5, 2026 | Proposed Sale | $35.49 | 20,000 | $709.8K | — | |